Background/objective: Schizophrenia is a chronic and disabling psychiatric disorder that
requires lifelong medication. The past 15 years led to the introduction of a number of new …

Despite treatment advances over the past decades, schizophrenia remains one of the most
severe psychiatric disorders that is associated with a chronic relapsing course and marked …

Despite the expansion of available antipsychotic drugs over the past 50 years, functional
outcomes for individuals with schizophrenia have not markedly improved. These agents are …

Schizophrenia is an illness that has been recognized for millennia; despite this, the
discovery of antipsychotic medications for its treatment has occurred only in the past half …

Despite pharmacologic advances, the treatment of schizophrenia remains a challenge, and
suboptimal outcomes are still all too frequent. Although treatment goals of response …

Schizophrenia: Overview and Treatment Options - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

Affecting up to 1% of the global population, schizophrenia is a chronic, disabling psychiatric
disorder that has profound effects on patients, families, and caretakers due to its tremendous …

Schizophrenia is a debilitating illness with a lifetime prevalence estimate of 0.6% and
consists of symptoms from the positive, negative, and cognitive domains. Social support …

Introduction: In this review, the authors describe medications in phase III of clinical
development for schizophrenia and schizoaffective disorder, and provide an opinion on how …